share_log
Reuters ·  May 7 16:09
Adaptive Biotechnologies Corp: Cash, Cash Equivalents and Marketable Securities Was $308.9 Mln as of March 31, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment